Mazdutide Shows Significant Weight Loss in Phase 3 Trial
Key Summary Mazdutide, a dual GLP-1 and glucagon receptor agonist, achieved 16.65% mean weight loss in adults with obesity. 84.3%
Read MoreKey Summary Mazdutide, a dual GLP-1 and glucagon receptor agonist, achieved 16.65% mean weight loss in adults with obesity. 84.3%
Read MoreKey Summary Brazil is launching the Our Genes Project, a nationwide genetic screening program for prospective parents. The initiative will
Read MoreKey Summary Researchers found that exposure to nature and time spent outdoors are associated with a more diverse nasal microbiome.
Read MoreKey Summary A new longitudinal study found that fatherhood was associated with lower all-cause mortality among Black men by middle
Read MoreKey Summary Researchers at the University of Pennsylvania successfully used CAR T-cell therapy to reduce harmful antibodies in highly sensitized
Read MoreKey Summary A 30-year study involving 147,374 adults found that 90–120 minutes of weekly strength training was associated with the
Read MoreKey Points Summary New Alzheimer’s drugs such as donanemab and lecanemab are generating optimism but remain controversial due to modest
Read MoreKey Takeaways Researchers are identifying “gut keystone bacteria” that help maintain microbiome stability and influence disease risk. Diet directly affects
Read MoreKey Summary A prospective study published in Scientific Reports found that persistent pregnancy nausea may indicate higher anxiety and depression
Read MoreKey Summary A new report in The Lancet Regional Health – Europe warns that chronic liver disease is becoming a
Read More